GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Net Current Asset Value

Biogena Group Invest AG (WBO:BIO) Net Current Asset Value : €0.24 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Biogena Group Invest AG's net current asset value per share for the quarter that ended in Jan. 2024 was €0.24.

The historical rank and industry rank for Biogena Group Invest AG's Net Current Asset Value or its related term are showing as below:

WBO:BIO' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 7.75   Med: 11.03   Max: 28.73
Current: 8.58

During the past 4 years, the highest Price-to-Net-Current-Asset-Value Ratio of Biogena Group Invest AG was 28.73. The lowest was 7.75. And the median was 11.03.

WBO:BIO's Price-to-Net-Current-Asset-Value is ranked worse than
68.83% of 969 companies
in the Consumer Packaged Goods industry
Industry Median: 4.85 vs WBO:BIO: 8.58

Biogena Group Invest AG Net Current Asset Value Historical Data

The historical data trend for Biogena Group Invest AG's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Net Current Asset Value Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Net Current Asset Value
0.15 0.28 0.25 0.24

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Net Current Asset Value 0.15 0.28 0.25 0.24

Competitive Comparison of Biogena Group Invest AG's Net Current Asset Value

For the Packaged Foods subindustry, Biogena Group Invest AG's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's Price-to-Net-Current-Asset-Value Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Price-to-Net-Current-Asset-Value falls into.



Biogena Group Invest AG Net Current Asset Value Calculation

Biogena Group Invest AG's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Jan. 2024 is calculated as

Net Current Asset Value Per Share(A: Jan. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1.343-0.366-0-0)/3.99
=0.24

Biogena Group Invest AG's Net Current Asset Value (NCAV) per share for the quarter that ended in Jan. 2024 is calculated as

Net Current Asset Value Per Share(Q: Jan. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1.343-0.366-0-0)/3.99
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Biogena Group Invest AG Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.

Biogena Group Invest AG (WBO:BIO) Headlines